-
Mashup Score: 1Guillain-Barré syndrome: Honing treatment strategies - 7 month(s) ago
Classic subtypes of Guillain-Barré syndrome are varying manifestations of a shared disease process, novel insights into the disease indicate. This understanding is yielding new treatment strategies.
Source: www.mdedge.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Guillain-Barré syndrome: Honing treatment strategies - 7 month(s) ago
Classic subtypes of Guillain-Barré syndrome are varying manifestations of a shared disease process, novel insights into the disease indicate. This understanding is yielding new treatment strategies.
Source: www.mdedge.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 2Wolters Kluwer Health - 12 month(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 1RareCare - National Organization for Rare Disorders - 1 year(s) ago
NORD’s Patient Assistance Programs Since 1987, NORD has provided assistance programs to help patients obtain life-saving or life-sustaining medication they could not otherwise afford. These programs provide medication, financial assistance with insurance premiums and co-pays, diagnostic testing assistance, and travel assistance for clinical trials or consultation with disease specialists. …
Categories: Latest Headlines, Rare DiseaseTweet-
Our Guillain-Barre Syndrome Emergency Relief Program provides financial aid to people with #GuillainBarreSyndrome when faced with unexpected non-medical expenses. For info, email gbsassistance@rarediseases.org. Access all NORD Patient Assistance Programs: https://t.co/3hCRMURLbP https://t.co/MsRLQyRc6N
-
-
Mashup Score: 1Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 0
The March 2022 replay of past episodes showcases a selection of interviews regarding the prognosis and treatment of Guillain-Barré syndrome. This episode features Drs. Ted Burns, Jeff Ratliff, and Michelle Mauermann in conversation with Dr. Bart Jacobs over the course of a decade, highlighting the progress he and his team have made in treating and predicting outcomes in GBS over time.
Source: directory.libsyn.comCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 3Predicting Outcomes in GBS - 2 year(s) ago
Dr. Jeff Ratliff talks with Dr. Bart Jacobs about his study on the validity and region-specificity of the modified Erasmus GBS Outcome Score in predicting the risk of walking inability in patients with Guillain-Barré syndrome. Read the .
Source: directory.libsyn.comCategories: Latest Headlines, NeurologyTweet-
Neurology Podcast: In today's episode, Dr. Bart Jacobs discusses his study on the validity and region-specificity of the modified Erasmus #GBS Outcome Score in predicting the risk of walking inability in patients with #GuillainBarréSyndrome. Listen now! https://t.co/GDqf9EOTC4 https://t.co/34stpEIaDd
-
-
Mashup Score: 3
Reviewing ivermectin and aducanumab data, the nature of reality, masks & kids, Johnson & Johnson side effects, and much more!
Source: ZDoggMDCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 4Wolters Kluwer Health - 3 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…
Source: journals.lww.comCategories: Latest Headlines, NeurologyTweet-
Experts say direct causality hasn't been proven between #COVID19 #vaccines & neurologic events & the vaccine's benefits outweigh the small potential risks for #GuillainBarrésyndrome, #Bellspalsy or other disorders.#neurology @astasia_abasia @mike_the_nerve https://t.co/kOG7RQped4 https://t.co/URoSAzKZlD
-
-
Mashup Score: 6Wolters Kluwer Health - 3 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…
Source: journals.lww.comCategories: Latest Headlines, NeurologyTweet-
Direct causality has not been proven between neurologic complications & the #COVID19 #vaccine. Experts say benefits of the vaccine outweigh the small potential risks for #GuillainBarrésyndrome, #Bellspalsy & other disorders.@StephenKeddie @ErinFeinstein https://t.co/sXZFA6md8M https://t.co/mXyHO6W2Pn
-
#GuillainBarrésyndrome: Honing treatment strategies #MedTwitter https://t.co/W9hmOHuyCi https://t.co/50Ll8b22oZ